BICO GROUP AK B O.N. stock forum
ONVO - Bioprinting could be a major disruptor for 2050. But major barriers exist. Technological Leadership:
A company developing superior bioprinting hardware and software platforms could establish itself as a standard.
Example: BICO Group (formerly CELLINK) stands out for its comprehensive ecosystem of bioprinters, bioinks, and software.
Widespread Adoption:
The company needs to see its technology widely adopted across industries, including healthcare, pharmaceuticals, and academia.
Example: Organovo has carved a niche in bioprinted tissue for drug testing and regenerative medicine.
Scalability and Market Reach:
The ability to scale production and expand into new markets is critical.
Example: Allevi (part of 3D Systems) benefits from its parent company’s scale and access to global markets.
Interdisciplinary Integration:
Success will require seamless integration of bioprinting with AI, robotics, and other emerging technologies.
Example: Aspect Biosystems leverages advanced microfluidics for precision bioprinting, appealing to both academic and commercial sectors.
Visionary Leadership and R&D:
Companies investing heavily in R&D to stay ahead in innovation will lead.
Example: Poietis excels in precision laser-assisted bioprinting and aims to lead in creating implantable tissues.
Partnerships and Ecosystem:
Collaborations with pharmaceutical companies, hospitals, and universities will accelerate progress.
Example: EnvisionTEC (Desktop Metal) already has a strong presence in healthcare and benefits from a larger 3D printing portfolio.
If I were to narrow it down, BICO Group (CELLINK) has the potential to dominate the field due to its diversified product line, strong research focus, and ability to create a complete ecosystem of hardware, software, and materials—similar to how NVIDIA built its dominance through GPUs and CUDA platforms.
However, the field is nascent, and disruptors could emerge as the technology matures. Watching how these companies expand their market share and drive adoption over the next decade will be crucial.
ONVO, 
BICO